Hirohata S - Search Results

1

Reversible focal neurological deficits in systemic lupus erythematosus: report of 2 cases and review of the literature.

Kimura M, Aramaki K, Wada T, Nishi K, Matsushita R, Iizuka N, Hashimoto A, Tanaka S, Ishikawa A, Endo H, Hirohata S. Kimura M, et al. Among authors: hirohata s. J Neurol Sci. 2008 Sep 15;272(1-2):71-6. doi: 10.1016/j.jns.2008.04.022. Epub 2008 Jun 5. J Neurol Sci. 2008. PMID: 18538345 Review.

2

Cerebral hemiatrophy in systemic lupus erythematosus: report of a case.

Hirohata S, Moroi Y, Yoshinoya S, Ishizaka N, Miyamoto T, Momose T. Hirohata S, et al. Jpn J Med. 1990 Jul-Aug;29(4):423-8. doi: 10.2169/internalmedicine1962.29.423. Jpn J Med. 1990. PMID: 2273627 Free article.

3

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.

Hirohata S, Miyamoto T. Hirohata S, et al. Arthritis Rheum. 1990 May;33(5):644-9. doi: 10.1002/art.1780330506. Arthritis Rheum. 1990. PMID: 2346520

4

HIV induced systemic lupus erythematosus.

Itoh K, Nishioka Y, Hirohata S, Inoue T, Ito K, Kimura M, Mori S. Itoh K, et al. Among authors: hirohata s. Lupus. 1994 Jun;3(3):205-6. doi: 10.1177/096120339400300313. Lupus. 1994. PMID: 7951307 No abstract available.

5

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

Hirohata S, Suda H, Hashimoto T. Hirohata S, et al. J Neurol Sci. 1998 Aug 14;159(2):181-5. doi: 10.1016/s0022-510x(98)00165-8. J Neurol Sci. 1998. PMID: 9741405 Clinical Trial.

6

Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet's syndrome.

Kawai M, Hirohata S. Kawai M, et al. Among authors: hirohata s. J Neurol Sci. 2000 Oct 1;179(S 1-2):132-9. doi: 10.1016/s0022-510x(00)00403-2. J Neurol Sci. 2000. PMID: 11054497

7

Regulation of human B cell function by sulfasalazine and its metabolites.

Hirohata S, Ohshima N, Yanagida T, Aramaki K. Hirohata S, et al. Int Immunopharmacol. 2002 Apr;2(5):631-40. doi: 10.1016/s1567-5769(01)00186-2. Int Immunopharmacol. 2002. PMID: 12013503

8

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years.

Kikuchi H, Aramaki K, Hirohata S. Kikuchi H, et al. Among authors: hirohata s. Adv Exp Med Biol. 2003;528:575-8. doi: 10.1007/0-306-48382-3_117. Adv Exp Med Biol. 2003. PMID: 12918768 Clinical Trial. No abstract available.

9

Autoimmune hepatitis in a patient with systemic lupus erythematosus.

Iwai M, Harada Y, Ishii M, Tanaka S, Muramatsu A, Mori T, Nakashima T, Okanoue T, Hirohata S. Iwai M, et al. Among authors: hirohata s. Clin Rheumatol. 2003 Sep;22(3):234-6. doi: 10.1007/s10067-002-0689-7. Clin Rheumatol. 2003. PMID: 14505218

10

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.

Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M. Yajima N, et al. Among authors: hirohata s. Arthritis Rheum. 2005 Jun;52(6):1670-5. doi: 10.1002/art.21042. Arthritis Rheum. 2005. PMID: 15934075 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters